Last updated at 03 Jul 2024 12:15 PM
Director
DIN: 09595024
Vimal Chandubhai Gadhiya is currently associated with 3 companies in various capacities such as Additional Director and Director. They serve as a Director at MANISH ESTATES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09595024.Vimal Chandubhai Gadhiya is currently involved in 2 different roles. Their most recent position is with SPECTRUM CLINICAL RESEARCH PRIVATE LIMITED as a Director. The first company Vimal Chandubhai Gadhiya was appointed to as a director was MANISH ESTATES PRIVATE LIMITED. Vimal Chandubhai Gadhiya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Vimal Chandubhai Gadhiya is currently associated with 3 companies in various capacities such as Additional Director and Director. They serve as a Director at MANISH ESTATES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09595024.Vimal Chandubhai Gadhiya is currently involved in 2 different roles. Their most recent position is with SPECTRUM CLINICAL RESEARCH PRIVATE LIMITED as a Director. The first company Vimal Chandubhai Gadhiya was appointed to as a director was MANISH ESTATES PRIVATE LIMITED. Vimal Chandubhai Gadhiya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
9 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MANISH ESTATES PRIVATE LIMITED | Additional Director | 01-May-2022 |
| VEENA PROPERTIES PRIVATE LIMITED | Additional Director | 01-May-2022 |
| SPECTRUM CLINICAL RESEARCH PRIVATE LIMITED | Director | 16-Aug-2023 |